Atherosclerosis With Immune Checkpoint Inhibitor Therapy: Evidence, Diagnosis, and Management: <i>JACC: CardioOncology</i> State-of-the-Art Review.

JACC CardioOncol · 2022 · PMC9830225 · PMID 36636438

Europe PMC DOI

hedged sentence

0.0870

closest p · 1.7× alpha

0.0870

boldest claim

The sentences

of borderline significanceP = 0.087so close (0.05 < p ≤ 0.1)

Stratified by subgroups, an increased HR in women of 6.0 compared with an HR in men of 3.93 was observed; however, the difference was of borderline significance ( P = 0.087). 31 Sex differences in ICI therapy, atherosclerosis, and CV adverse events could be related to genetic and hormonal factors.

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.